175 related articles for article (PubMed ID: 38074953)
1. The Comparative Efficacy of Ceftazidime-Avibactam with or without Aztreonam vs Polymyxins for Carbapenem-resistant Enterobacteriaceae Infections: A Prospective Observational Cohort Study.
Vijayakumar M; Selvam V; Renuka MK; Rajagopalan RE
Indian J Crit Care Med; 2023 Dec; 27(12):923-929. PubMed ID: 38074953
[TBL] [Abstract][Full Text] [Related]
2. Ceftazidime-avibactam with or without Aztreonam vs Polymyxin-based Combination Therapy for Carbapenem-resistant Enterobacteriaceae: A Retrospective Analysis.
Prayag PS; Patwardhan SA; Panchakshari S; Sambasivam R; Dhupad S; Soman RN; Prayag AP
Indian J Crit Care Med; 2023 Jun; 27(6):444-450. PubMed ID: 37378372
[TBL] [Abstract][Full Text] [Related]
3. Ceftazidime-avibactam versus polymyxins in treating patients with carbapenem-resistant Enterobacteriaceae infections: a systematic review and meta-analysis.
Chen J; Hu Q; Zhou P; Deng S
Infection; 2024 Feb; 52(1):19-28. PubMed ID: 37878197
[TBL] [Abstract][Full Text] [Related]
4. In Vitro Activities and Inoculum Effects of Ceftazidime-Avibactam and Aztreonam-Avibactam against Carbapenem-Resistant
Kim T; Lee SC; Bae M; Sung H; Kim MN; Jung J; Kim MJ; Kim SH; Lee SO; Choi SH; Kim YS; Chong YP
Antibiotics (Basel); 2020 Dec; 9(12):. PubMed ID: 33334045
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant
Chen Y; Huang HB; Peng JM; Weng L; Du B
Microbiol Spectr; 2022 Apr; 10(2):e0260321. PubMed ID: 35377233
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of ceftazidime-avibactam versus polymyxins in the treatment of carbapenem-resistant Enterobacteriaceae infection: a systematic review and meta-analysis.
Yang P; Li Y; Wang X; Chen N; Lu X
BMJ Open; 2023 May; 13(5):e070491. PubMed ID: 37137556
[TBL] [Abstract][Full Text] [Related]
7. Ceftazidime-avibactam alone or in combination with Aztreonam versus Polymyxins in the management of carbapenem-Resistant Klebsiella pneumoniae nosocomial Infections (CAPRI study): a retrospective cohort study from South India.
Sree RA; Gupta A; Gupta N; Veturi S; Reddy LSK; Begum M; Shravani E; Challa HR; Reddy SS; Singamsetty A; Arumilli M; Reddy PN; Tirlangi PK
Infection; 2024 Apr; 52(2):429-437. PubMed ID: 37697224
[TBL] [Abstract][Full Text] [Related]
8. Ceftazidime-avibactam in the treatment of bacteremia due to carbapenem-resistant gram-negative bacteria in hematological patients: Experience in a single center.
Zhen S; Lin Q; Chen Z; Shen Y; Chen X; Pang A; Yang D; Zhang R; Ma Q; He Y; Wei J; Zhai W; Jiang E; Han M; Wang J; Feng S
J Infect Chemother; 2024 Jul; 30(7):608-615. PubMed ID: 38215820
[TBL] [Abstract][Full Text] [Related]
9. Ceftazidime-avibactam in the treatment of infections from carbapenem-resistant Klebsiella pneumoniae: Ceftazidime-avibactam against CR-KP infections.
Gu J; Xu J; Zuo TT; Chen YB
J Glob Antimicrob Resist; 2021 Sep; 26():20-25. PubMed ID: 34020072
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of ceftazidime-avibactam in the treatment of infections due to Carbapenem-resistant Enterobacteriaceae.
Alraddadi BM; Saeedi M; Qutub M; Alshukairi A; Hassanien A; Wali G
BMC Infect Dis; 2019 Sep; 19(1):772. PubMed ID: 31484510
[TBL] [Abstract][Full Text] [Related]
11. Ceftazidime-Avibactam versus Colistin for the Treatment of Infections Due to Carbapenem-Resistant Enterobacterales: A Multicenter Cohort Study.
Almangour TA; Ghonem L; Aljabri A; Alruwaili A; Al Musawa M; Damfu N; Almalki MS; Alattas M; Abed H; Naeem D; Almalki N; Alhifany AA
Infect Drug Resist; 2022; 15():211-221. PubMed ID: 35125877
[TBL] [Abstract][Full Text] [Related]
12. Ceftazidime-Avibactam To Treat Life-Threatening Infections by Carbapenem-Resistant Pathogens in Critically Ill Mechanically Ventilated Patients.
Tsolaki V; Mantzarlis K; Mpakalis A; Malli E; Tsimpoukas F; Tsirogianni A; Papagiannitsis C; Zygoulis P; Papadonta ME; Petinaki E; Makris D; Zakynthinos E
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31818820
[TBL] [Abstract][Full Text] [Related]
13. Treating complicated carbapenem-resistant enterobacteriaceae infections with ceftazidime/avibactam: a retrospective study with molecular strain characterisation.
Krapp F; Grant JL; Sutton SH; Ozer EA; Barr VO
Int J Antimicrob Agents; 2017 Jun; 49(6):770-773. PubMed ID: 28389354
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy and drug resistance of ceftazidime-avibactam in the treatment of Carbapenem-resistant gram-negative bacilli infection.
Xiao S; Fu Q; Miao Y; Zhao M; Lu S; Xu J; Zhao W
Front Microbiol; 2023; 14():1198926. PubMed ID: 37664109
[TBL] [Abstract][Full Text] [Related]
15. Ceftazidime/Avibactam versus Polymyxin B in the Challenge of Carbapenem-Resistant
Chen J; Liang Q; Chen X; Wu J; Wu Y; Teng G; Huang M
Infect Drug Resist; 2022; 15():655-667. PubMed ID: 35241917
[TBL] [Abstract][Full Text] [Related]
16. Retrospective Tertiary Care-Based Cohort Study on Clinical Characteristics and Outcomes of Ceftazidime-Avibactam-Resistant Carbapenem-Resistant
Ahmed F; Abraham B; Kamal Saeed N; Mohamed Naser H; Sridharan K
Crit Care Res Pract; 2024; 2024():3427972. PubMed ID: 38868174
[TBL] [Abstract][Full Text] [Related]
17. Ceftazidime/Avibactam-Based Versus Polymyxin B-Based Therapeutic Regimens for the Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infection in Critically Ill Patients: A Retrospective Cohort Study.
Zheng G; Cai J; Zhang L; Chen D; Wang L; Qiu Y; Deng H; Bai H; Bian X; He J
Infect Dis Ther; 2022 Oct; 11(5):1917-1934. PubMed ID: 35976531
[TBL] [Abstract][Full Text] [Related]
18. In vitro Activity of Ceftazidime-Avibactam and Aztreonam-Avibactam Against Carbapenem-resistant
Zou C; Wei J; Shan B; Chen X; Wang D; Niu S
Infect Drug Resist; 2020; 13():3563-3568. PubMed ID: 33116675
[TBL] [Abstract][Full Text] [Related]
19. CP-CRE/non-CP-CRE Stratification And CRE Resistance Mechanism Determination Help In Better Managing CRE Bacteremia Using Ceftazidime-Avibactam And Aztreonam-Avibactam.
Zou H; Xiong SJ; Lin QX; Wu ML; Niu SQ; Huang SF
Infect Drug Resist; 2019; 12():3017-3027. PubMed ID: 31576152
[TBL] [Abstract][Full Text] [Related]
20. Ceftazidime-Avibactam as Salvage Therapy for Infections Caused by Carbapenem-Resistant Organisms.
Temkin E; Torre-Cisneros J; Beovic B; Benito N; Giannella M; Gilarranz R; Jeremiah C; Loeches B; Machuca I; Jiménez-Martín MJ; Martínez JA; Mora-Rillo M; Navas E; Osthoff M; Pozo JC; Ramos Ramos JC; Rodriguez M; Sánchez-García M; Viale P; Wolff M; Carmeli Y
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27895014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
